Genome Editing Market to Reach US$ 17.5 Billion by End of 2031: Transparency Market Research, Inc.

In 2022, the global 𝐆𝐞𝐧𝐨𝐦𝐞 𝐄𝐝𝐢𝐭𝐢𝐧𝐠 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 reached a valuation of US$ 5.5 billion. Forecasts indicate a robust advancement, with a projected Compound Annual Growth Rate (CAGR) of 13.9% from 2023 to 2031, culminating in a figure exceeding US$ 17.5 billion by the conclusion of 2031.

The genome editing market experiences significant growth driven by several factors including the rise in prevalence of genetic disorders, increased demand for personalized medicine, and the expanding applications of genome editing technologies in therapeutic areas.

Additionally, the emergence of CRISPR-Cas9 as a versatile and precise genome editing tool presents lucrative opportunities for market expansion. This technology enables researchers to edit genes with unparalleled accuracy, further fueling market growth.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=46494&utm_source=OpenPR&utm_campaign=MansiR_OpenPR

The surge in demand for genome editing tools and services spans across research institutions, biopharmaceutical companies, and clinical settings, propelling market progress. Notably, there is a growing trend in the adoption of CRISPR technology for developing gene therapies and utilizing genome editing in agriculture for crop improvement.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧

Genome editing, a groundbreaking technique, allows precise modification of DNA, facilitating targeted changes to genetic elements. With applications in agriculture, medicine, and biotechnology, it promises significant advancements.

In agriculture, genome editing enhances crops by imparting traits like pest resistance, increased yield, and improved nutrition.

In medicine, genome editing shows potential in treating genetic disorders by rectifying or substituting defective genes. The CRISPR-Cas9 system has revolutionized this field, refining techniques for greater accuracy and reduced off-target effects.

Continual advancements include techniques like base editing and prime editing, offering heightened precision and minimized unintended alterations. Ethical debates center on responsible genome editing use, especially concerning human germline editing.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

Merck KGaA, AstraZeneca, Takara Bio Inc., Cellectis SA, CRISPR Therapeutics., Cibus Inc., RECOMBINETICS, Sangamo Therapeutics, and Thermo Fisher Scientific, Inc.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

Technology

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
Transcription Activator-like Effector Nuclease (TALEN)
Zinc Finger Nuclease (ZFN)
Other Technologies

Application

Cell Line Editing
Animal Genome Editing
Plant Genome Editing
Others

End-user

Pharmaceutical Companies and Biotechnology Companies
Academics and Government Research Institutes
Clinical Research Organizations

𝐂𝐑𝐈𝐒𝐏𝐑 𝐆𝐚𝐢𝐧𝐢𝐧𝐠 𝐓𝐫𝐚𝐜𝐭𝐢𝐨𝐧

The genome editing market is segmented by technology, which includes Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-like Effector Nuclease (TALEN), Zinc Finger Nuclease (ZFN), and other technologies.

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) stands out as the leading technology in genome editing due to its simplicity, versatility, and cost-effectiveness.

Its user-friendly nature has made CRISPR widely adopted across the scientific community, enabling easier implementation of genome editing techniques. By redesigning the guide RNA, researchers can swiftly adapt and target different genes, accelerating research and development across various fields, including agriculture and medicine.

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In February, 2022, Intellia Therapeutics, Inc., a clinical-stage genome editing company focused on developing curative therapeutics leveraging CRISPR-based technologies, announced acquisition of Rewrite Therapeutics, Inc., a private biotechnology company focused on advancing novel DNA writing technologies. Rewrite's technology will be delivered using Intellia's lipid nanoparticle (LNP) technology and adeno-associated virus (AAV) vectors.

In November 2020, Eli Lilly and Company and Precision BioSciences, Inc. announced a research collaboration and exclusive license agreement to utilize Precision's proprietary ARCUS genome editing platform for the research and development of potential in vivo therapies for genetic disorders, with an initial focus on Duchenne muscular dystrophy (DMD) and two other undisclosed gene targets.

𝐆𝐞𝐭 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭, 𝐈𝐧𝐬𝐭𝐚𝐧𝐭𝐥𝐲:
https://www.transparencymarketresearch.com/checkout.php?rep_id=46494<ype=S&utm_source=OpenPR&utm_campaign=MansiR_OpenPR

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬:

Drivers:

Growing demand for personalized medicine, advancements in CRISPR/Cas9 technology, increasing prevalence of genetic disorders, and rising investments in genomics research.

Challenges:

Ethical concerns surrounding genome editing, regulatory uncertainties, off-target effects, and intellectual property disputes pose challenges to market growth.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

Adoption of CRISPR/Cas9 technology for gene therapy.
Integration of artificial intelligence and machine learning in genome editing.
Rising focus on developing gene-edited crops for sustainable agriculture.
Collaborations and partnerships among key market players for product development and commercialization.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

-Evaluation of market dynamics, including drivers, challenges, and opportunities.
-Analysis of market segmentation by service type, sourcing type, application, industry vertical, and region.
-Assessment of competitive landscape, key market players, and recent developments.
-Examination of regulatory frameworks and their impact on market growth.
-Identification of emerging trends and future market outlook.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐑𝐞𝐟𝐮𝐫𝐛𝐢𝐬𝐡𝐞𝐝 𝐃𝐞𝐧𝐭𝐚𝐥 𝐋𝐚𝐛 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/02/14/2607990/0/en/Refurbished-Dental-Lab-Equipment-Market-to-Reach-US-6-8-Billion-by-End-of-2031-Transparency-Market-Research-Inc.html

𝐄𝐥𝐞𝐜𝐭𝐫𝐢𝐜 𝐁𝐮𝐠 𝐙𝐚𝐩𝐩𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/02/14/2607631/0/en/Electric-Bug-Zapper-Market-Value-to-reach-US-93-4-million-by-2031-Transparency-Market-Research-Inc.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com        
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.